Skybiotech Healthcare Board Meeting on Nov 10 to Approve Un-Audited Financials

Skybiotech Healthcare Ltd has announced that its Board of Directors will convene on November 10, 2026. The primary agenda item for this meeting is the consideration and approval of the company's un-audited financial results for the quarter and half-year ended September 30, 2026. A limited review report will also be presented. The meeting will adhere to SEBI (LODR) Regulations, 2015, specifically Regulation 29(1)(a) concerning board meeting disclosures.